RxDoctor Payments Data

Garrett Bostwick, PA

Physician Assistant · Wilmington, NCNPI 1245783745

Payments from drug & device makers

$2,845in general payments, 2019–2025

Across 71 payments — averaging $40.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$821
  • Atricure, Inc.$705
  • Kestra Medical Technology Services, Inc.$393
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$346
  • Medtronic$310
  • Abbott$197
  • plus $74 from 4 others

What the payments were for

  • Food & beverage$2,83099%
  • Education$151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,845 in reported general payments places this provider in the 85th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$27,521
Medicare patients
208
Services billed
317

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban319$298,218
XareltoRivaroxaban52$41,215
EntrestoSacubitril/Valsartan24$34,622
Dofetilide124$19,694
FarxigaDapagliflozin Propanediol12$17,187
Flecainide Acetate129$3,558
Amiodarone Hcl78$1,528
Diltiazem 24hr Er (Cd)Diltiazem Hcl42$1,067
Metoprolol Succinate92$739
SotalolSotalol Hcl34$603
Torsemide18$492
Carvedilol78$434
Tiadylt ErDiltiazem Hcl12$390
ClopidogrelClopidogrel Bisulfate39$369
Atorvastatin Calcium46$281

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$18$41,21552 claims
AstraZenecaFarxiga$19$17,18712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Wilmington

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →